Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-METOPROLOL (TYPE L) | 100MG | TABLET | Resolved | 2024-10-18 | 2024-12-06 | 240642 |
| APO-METOPROLOL (TYPE L) | 50MG | TABLET | Resolved | 2024-11-07 | 2024-12-06 | 242205 |
| APO-METOPROLOL (TYPE L) | 50MG | TABLET | Resolved | 2025-02-20 | 2025-05-16 | 250935 |
| APO-METOPROLOL (TYPE L) | 100MG | TABLET | Resolved | 2025-04-10 | 2025-07-04 | 254844 |
| APO-METOPROLOL (TYPE L) | 100MG | TABLET | Resolved | 2025-05-01 | 2025-07-04 | 256316 |
| APO-METOPROLOL (TYPE L) | 100MG | TABLET | Resolved | 2025-08-21 | 2025-08-29 | 265820 |
| APO-METOPROLOL (TYPE L) | 100MG | TABLET | Resolved | 2020-04-29 | 2020-08-05 | 113394 |
| APO-METRONIDAZOLE | 500MG | CAPSULE | Resolved | 2022-04-08 | 2022-05-14 | 158364 |
| APO-METRONIDAZOLE | 500MG | CAPSULE | Resolved | 2024-06-06 | 2024-10-25 | 229749 |
| APO-METRONIDAZOLE | 500MG | CAPSULE | Resolved | 2025-01-23 | 2025-03-07 | 248483 |
| APO-METRONIDAZOLE TABLETS | 250MG | TABLET | Resolved | 2024-10-04 | 2024-11-01 | 239361 |
| APO-METRONIDAZOLE TABLETS | 250MG | TABLET | Resolved | 2025-01-30 | 2025-02-14 | 249080 |
| APO-METRONIDAZOLE TABLETS | 250MG | TABLET | Resolved | 2025-09-18 | 2025-10-16 | 267476 |
| APO-MIDODRINE | 5MG | TABLET | Resolved | 2021-04-16 | 2021-04-26 | 137584 |
| APO-MIDODRINE | 2.5MG | TABLET | Resolved | 2022-01-07 | 2022-04-22 | 152313 |
| APO-MIDODRINE | 5MG | TABLET | Resolved | 2022-01-21 | 2022-04-29 | 153278 |
| APO-MIDODRINE | 5MG | TABLET | Resolved | 2023-07-27 | 2023-09-22 | 200200 |
| APO-MIDODRINE | 5MG | TABLET | Resolved | 2023-11-06 | 2023-12-22 | 209375 |
| APO-MIDODRINE | 2.5MG | TABLET | Resolved | 2023-11-17 | 2023-12-22 | 210701 |
| APO-MIDODRINE | 5MG | TABLET | Resolved | 2024-01-26 | 2024-05-24 | 217472 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |